Skip to Content

    Rising health care spending and an aging population mean good health for this generic-drug maker, even as the government investigates industry pricing.

    (For more on Lannett, read This is the fastest growing company in the U.S.)

    41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

    Company Information

    Location
    Philadelphia, PA
    Industry
    Pharmaceuticals
    Sector
    Health Care
    Fortune 500 Rank-
    Fortune 500 Profile-
    Current Streak2
    Years on List2
    CEO
    Arthur P. Bedrosian
    Websitehttp://www.lannett.com

    Revenue, Net Income

    Revenue Past Four Quarters388
    Net Income Past Four Quarters140

    Growth Rates

    EPS 3 yr Annual Growth Rate314%
    Rev 3 yr Annual Growth Rate51%
    Total Return 3 yr Annual Rate141%
    Beat S&P 3 yr Total Return?
    yes

    Rank

    EPS Growth Rank1
    Revenue Growth Rank9
    Total Return Rank
    2